Ubs Group Ag Baxter International Inc Put Options Transaction History

Ubs Group Ag

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	SELL	$32.87 - $43.55 $9.22 Million - $12.2 Million	-280,400 Reduced 83.6%	55,000 $1.84 Million
Q1 2024 May 13, 2024	BUY	$37.88 - $43.77 $11.3 Million - $13 Million	297,900 Added 794.4%	335,400 $14.3 Million
Q4 2023 Feb 09, 2024	SELL	$31.71 - $38.95 $554,925 - $681,625	-17,500 Reduced 31.82%	37,500 $1.45 Million
Q2 2023 Aug 11, 2023	BUY	$39.98 - $47.68 $219,889 - $262,240	5,500 Added 11.11%	55,000 $2.51 Million
Q1 2023 May 12, 2023	SELL	$37.58 - $52.57 $7.98 Million - $11.2 Million	-212,400 Reduced 81.1%	49,500 $2.01 Million
Q3 2022 Nov 10, 2022	BUY	$53.86 - $66.8 $14.1 Million - $17.5 Million	261,900 New	261,900 $14.1 Million
Q4 2020 Feb 11, 2021	BUY	$75.39 - $82.36 $1.32 Million - $1.44 Million	17,500 Added 233.33%	25,000 $2.01 Million
Q2 2020 Jul 31, 2020	SELL	$78.66 - $94.14 $13.1 Million - $15.7 Million	-166,500 Reduced 95.69%	7,500 $646,000
Q1 2017 Nov 14, 2017	BUY	N/A	174,000	174,000 $9.02 Million

998

450M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.